InvestLog
MNPR logo

MNPR

Monopar Therapeutics Inc.NASDAQHealthcare
$55.13-2.63%ClosedMarket Cap: $368.4M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-30Chardan CapitalmaintainBuyBuy
2026-02-23BTIGmaintainBuyBuy
2026-01-29Chardan CapitalmaintainBuyBuy
2026-01-14BTIGmaintainBuyBuy
2025-11-14Raymond JamesdowngradeOutperformStrong Buy
2025-11-13Chardan CapitalmaintainBuyBuy
2025-10-06Raymond JamesmaintainStrong BuyStrong Buy
2025-10-02OppenheimermaintainOutperformOutperform
2025-09-29HC Wainwright & Co.maintainBuyBuy
2025-09-25Piper SandlermaintainOverweightOverweight
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-3.30$400.0K10
Fri Dec 31$-3.61$19.3M7
Sun Dec 31$-0.18$93.1M8
Mon Dec 31$3.50$204.0M6